Influence of Insurance Status and Vaccine Cost on Physicians’ Administration of Pneumococcal Conjugate Vaccine
* Child Health Evaluation and Research (CHEAR) Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, Michigan
Division of General Internal Medicine, University of Michigan, Ann Arbor, Michigan
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia
Objective. In 2000, heptavalent pneumococcal conjugate vaccine (PCV7) was recommended for children younger than 2 years, but its high cost relative to other universally recommended childhood immunizations and variability in insurance coverage for the vaccine raised concerns. We investigated the influence of PCV7 cost and insurance coverage on physician recommendation of PCV7 to their patients and administration of PCV7 in their practices.
Methods. We conducted a mail survey from April to July 2001 of a random sample of 833 pediatricians and 788 family physicians in 24 states with different vaccine financing strategies (Vaccines for Children [VFC]-only; enhanced VFC; universal purchase). Physicians specified the proportion of children in their practice with insurance coverage for PCV7, where they recommend administering PCV7, and whether they have concerns about the cost of PCV7.
Results. The response rate was 60%. Overall, 87% of physicians recommend PCV7 for children younger than 2 years (99% pediatricians; 68% family physicians). Among physicians who recommend PCV7, 98% said that they would administer the vaccine in their own practices for children whose insurance covers the vaccine. However, only 56% of physicians who recommend PCV7 reported that all children in their practices had insurance coverage for the vaccine, whereas 24% of physicians reported 86% to 99% of children with coverage and 20% reported 
85% of children with coverage. Among physicians in the last group with the lowest PCV7 insurance coverage rates in their practices, only 44% said that they would administer the vaccine in their own practices to children without PCV7 coverage, compared with 62% of physicians who provide care to children with higher rates of PCV7 coverage. Physicians in states with VFC-only vaccine financing strategies for PCV7 are less likely to administer PCV7 in their own practices to children without coverage than physicians in states with enhanced VFC and universal purchase strategies (48% vs 64% vs 74%). Almost one third of physicians who recommend PCV7 are concerned about the cost of PCV7; those with cost concerns are more likely to recommend that children without insurance coverage for PCV7 receive the vaccine at a public health clinic rather than in their own practices (45% vs 29%). Physicians with cost concerns are also more likely to say that they now screen children for insurance coverage more than for previously recommended vaccines (52% vs 21% for physicians without cost concerns).
Conclusions. Nationwide, physician adoption of PCV7 recommendations is high, but where physicians recommend that PCV7 be administered differs significantly by children’s variable insurance coverage for the vaccine and by state vaccine financing strategies. Physicians’ concerns about the cost of PCV7 may foreshadow their responses to future children’s vaccines that may be even more expensive.
Key Words: pneumococcal conjugate vaccine • health insurance • pediatrician • family physician • physician behavior
Abbreviations: PCV7, heptavalent pneumococcal conjugate vaccine • VFC, Vaccines for Children • ACIP, Advisory Committee on Immunization Practices • CDC, Centers for Disease Control and Prevention • PD, pediatricians • FP, family physicians
Received for publication Aug 22, 2002; Accepted Feb 3, 2003.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  G. D. Brandon, S. Adeniyi-Jones, S. Kirkby, D. Webb, J. F. Culhane, and J. S. Greenspan Are Outcomes and Care Processes for Preterm Neonates Influenced by Health Insurance Status? Pediatrics, July 1, 2009; 124(1): 122 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Freed, A. E. Cowan, and S. J. Clark Primary Care Physician Perspectives on Reimbursement for Childhood Immunizations Pediatrics, December 1, 2008; 122(6): 1319 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Lee, J. M. Santoli, C. Hannan, M. L. Messonnier, J. E. Sabin, D. Rusinak, C. Gay, S. M. Lett, and T. A. Lieu Gaps in Vaccine Financing for Underinsured Children in the United States JAMA, August 8, 2007; 298(6): 638 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Fairbrother, K. Broder, M. A. Staat, B. Schwartz, C. Heubi, S. Hiratzka, F. J. Walker, and A. L. Morrow Pediatricians' Adherence to Pneumococcal Conjugate Vaccine Shortage Recommendations in 2 National Shortages Pediatrics, August 1, 2007; 120(2): e401 - e409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kempe, M. F. Daley, U. D. Parashar, L. A. Crane, B. L. Beaty, S. Stokley, J. Barrow, C. Babbel, L. M. Dickinson, M.-A. Widdowson, et al. Will Pediatricians Adopt the New Rotavirus Vaccine? Pediatrics, January 1, 2007; 119(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Daley, N. Liddon, L. A. Crane, B. L. Beaty, J. Barrow, C. Babbel, L. E. Markowitz, E. F. Dunne, S. Stokley, L. M. Dickinson, et al. A National Survey of Pediatrician Knowledge and Attitudes Regarding Human Papillomavirus Vaccination Pediatrics, December 1, 2006; 118(6): 2280 - 2289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Meyers, R. Mishori, J. McCann, J. Delgado, A. S. O'Malley, and E. Fryer Primary care physicians' perceptions of the effect of insurance status on clinical decision making. Ann. Fam. Med, September 1, 2006; 4(5): 399 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Freed, A. E. Cowan, S. J. Clark, J. Santoli, and J. Bradley Use of a New Combined Vaccine in Pediatric Practices Pediatrics, August 1, 2006; 118(2): e251 - e257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stokley, K. M. Shaw, L. Barker, J. M. Santoli, and A. Shefer Impact of State Vaccine Financing Policy on Uptake of Heptavalent Pneumococcal Conjugate Vaccine Am J Public Health, July 1, 2006; 96(7): 1308 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Mmeje and M. M. Davis Will Coverage for Child and Adolescent Immunizations Be Mandated for Insurance Plans in 2006? Lessons Learned From the Newborns' and Mothers' Health Protection Act of 1996 Pediatrics, July 1, 2006; 118(1): 388 - 392. [Full Text] [PDF]
|
|
|
|
|
|
K. R. Broder, A. MacNeil, S. Malone, B. Schwartz, A. L. Baughman, T. V. Murphy, L. K. Pickering, and J. S. Moran Who's Calling the Shots? Pediatricians' Adherence to the 2001-2003 Pneumococcal Conjugate Vaccine-Shortage Recommendations Pediatrics, June 1, 2005; 115(6): 1479 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Lieu, T. G. McGuire, and A. R. Hinman Overcoming Economic Barriers To The Optimal Use Of Vaccines Health Aff., May 1, 2005; 24(3): 666 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Farrell, S G Jenkins, and R R Reinert Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparators J. Med. Microbiol., November 1, 2004; 53(11): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
